Potassium Citrate Powder
100% Pure Food Grade Tri-Potassium Citrate Powder (Anhydrous Tripotassium Citrate)
Potassium is an alkalinizing mineral that is typically deficient in the American diet.
The primary source of dietary potassium is from fruits and vegetables.
Mild metabolic acidosis (MMA) results from low intakes of alkaline fruits and vegetables and
high intakes of grain and protein foods. This MMA can cause the gradual leaching of minerals from bone,
leading to osteoporosis. MMA and/or lack of urinary citrate is also a metabolic factor in the formation
of kidney stones.
Potassium citrate serves as a source of both potassium and citrate and has been found useful for:
- increasing bone mineral density and improving bone architecture (1-4)
- decreasing the formation of kidney stones by up to 93% (3-11)
- alkalinizing the body and reversing mild metabolic acidosis (7)
Potassium Citrate Powder is used to treat kidney damage and specifically, metabolic acidosis which is where the blood is more acidic than normal. Potassium Citrate Powder may be used to help pass kidney and bladder stones through the body easily and less painfully, as it causes the stones to break down while passing through the body.
Some people take Potassium Citrate Powder just to reduce the amount of acid in the urine or increase the pH levels- that is, to "alkalinize."
Suggested Use: Take as directed by your health care professional. DO NOT take more than recommended.
Doses in the studies range from 1 mEq/kg daily in children (10) up to 80 mEq (3120milligrams) daily total for adults. (7-8)
Eight grams (8g) of potassium citrate contains approximately 3,000mg potassium. This amount can be found in 1 and 1/4 tsp.
It is best taken in divided doses; that is, divided into two or three doses daily.
To use: Carefully measure and mix the desired amount of potassium citrate in a glass of warm water, mix well, and drink. Can be mixed with sugar-free flavored beverages - we recommend ZipFizz for a healthy "sports drink."
N373 - Potassium Citrate Powder, 454 grams / 1 pound - $23.97
Enter Quantity Desired and Click "Add To Cart" Button
Nutritional Facts: Net Wt.: 454 grams (1 lb)
CAS# 7681-11-0, Molecular Formula: C6H5K3O7, Molecular Weight: 306.4, 36% Potassium
NOTE: this is a Bulk Product: This product is supplied in bulk form and should be measured and used with careful accuracy and caution.
1.) Jehle S, Hulter HN, Krapf R. Effect of Potassium Citrate on Bone Density,
Microarchitecture, and Fracture Risk in Healthy Older Adults without Osteoporosis:
A Randomized Controlled Trial. J Clin Endocrinol Metab. 2012 Nov 15. [Epub ahead
2.) Harrington M, Cashman KD. High salt intake appears to increase bone resorption
in postmenopausal women but high potassium intake ameliorates this adverse effect.
Nutr Rev. 2003 May;61(5 Pt 1):179-83.
3.) Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R. Partial neutralization of the
acidogenic Western diet with potassium citrate increases bone mass in
postmenopausal women with osteopenia. J Am Soc Nephrol. 2006
Nov;17(11):3213-22. Epub 2006 Oct 11.
4.) Vescini F, Buffa A, La Manna G, Ciavatti A, Rizzoli E, Bottura A, Stefoni S,
Caudarella R. Long-term potassium citrate therapy and bone mineral density in
idiopathic calcium stone formers. J Endocrinol Invest. 2005 Mar;28(3):218-22.
5.) Lojanapiwat B, Tanthanuch M, Pripathanont C, Ratchanon S, Srinualnad S,
Taweemonkongsap T, Kanyok S, Lammongkolkul S. Alkaline citrate reduces stone
recurrence and regrowth after shockwave lithotripsy and percutaneous
nephrolithotomy. Int Braz J Urol. 2011 Sep-Oct;37(5):611-6.
6.) Pak CY, Peterson RD, Poindexter J. Prevention of spinal bone loss by potassium
citrate in cases of calcium urolithiasis. J Urol. 2002 Jul;168(1):31-4.
7.) Pak CY, Fuller C. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis
successfully treated with potassium citrate. Ann Intern Med. 1986 Jan;104(1):33-7.
8.) Preminger GM, Sakhaee K, Skurla C, Pak CY. Prevention of recurrent calcium
stone formation with potassium citrate therapy in patients with distal renal tubular
acidosis. J Urol. 1985 Jul;134(1):20-3.
9.) Robinson MR, Leitao VA, Haleblian GE, Scales CD Jr, Chandrashekar A, Pierre
SA, Preminger GM. Impact of long-term potassium citrate therapy on urinary profiles
and recurrent stone formation. J Urol. 2009 Mar;181(3):1145-50. Epub 2009 Jan 18.
10.) Sarica K, Erturhan S, Yurtseven C, Yagci F. Effect of potassium citrate therapy
on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in
children. J Endourol. 2006 Nov;20(11):875-9.
11.) Soygür T, Akbay A, Küpeli S. Effect of potassium citrate therapy on stone
recurrence and residual fragments after shockwave lithotripsy in lower caliceal
calcium oxalate urolithiasis: a randomized controlled trial. J Endourol. 2002